User menu

The Role of PPARgamma in Hepatocellular Carcinoma.

Bibliographic reference Borbath, Ivan ; Horsmans, Yves. The Role of PPARgamma in Hepatocellular Carcinoma.. In: PPAR research, Vol. 2008, p. 209520 (2008)
Permanent URL http://hdl.handle.net/2078.1/12601
  1. CA: Cancer Journal for Clinicians, 55, 74 (2005)
  2. Chang Mei-Hwei, Chen Chien-Jen, Lai Mei-Shu, Hsu Hsu-Mei, Wu Tzee-Chung, Kong Man-Shan, Liang Der-Cherng, Shau Wen-Yi, Chen Ding-Shinn, Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in Children, 10.1056/nejm199706263362602
  3. Mazzaferro Vincenzo, Romito Raffaele, Schiavo Marcello, Mariani Luigi, Camerini Tiziana, Bhoori Sherrie, Capussotti Lorenzo, Calise Fulvio, Pellicci Riccardo, Belli Giulio, Tagger Alessandro, Colombo Massimo, Bonino Ferruccio, Majno Pietro, Llovet Josep M., , Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis, 10.1002/hep.21415
  4. Michalik Liliane, Desvergne Béatrice, Wahli Walter, Peroxisome-proliferator-activated receptors and cancers: complex stories, 10.1038/nrc1254
  5. Saez Enrique, Tontonoz Peter, Nelson Michael C., Alvarez Jacqueline G.A., U Tze Ming, Baird Stephen M., Thomazy Vilmos A., Evans Ronald M., Activators of the nuclear receptor PPARγ enhance colon polyp formation, 10.1038/2042
  6. Rumi M A K, Sato H, Ishihara S, Kawashima K, Hamamoto S, Kazumori H, Okuyama T, Fukuda R, Nagasue N, Kinoshita Y, Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma, 10.1054/bjoc.2001.1821
  7. Koga H, Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells, 10.1053/jhep.2003.50186
  8. Okano Hiroshi, Shiraki Katsuya, Inoue Hidekazu, Yamanaka Takenari, Deguchi Masatoshi, Sugimoto Kazushi, Sakai Takahisa, Ohmori Shigeru, Fujikawa Katsuhiko, Murata Kazumoto, Nakano Takeshi, Peroxisome proliferator-activated receptor γ augments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma : , 10.1097/00001813-200201000-00007
  9. Toyoda M, A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells, 10.1136/gut.50.4.563
  10. Shen Y-C, Hsu C, Chen J-Y, Cheng A-L, Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines, 10.1038/sj.bjc.6602200
  11. Motomura Wataru, Takahashi Nobuhiko, Nagamine Miho, Sawamukai Mitsuko, Tanno Satoshi, Kohgo Yutaka, Okumura Toshikatsu, Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells, 10.1002/ijc.11561
  12. Koga H, Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell lines, 10.1053/jhep.2001.24024
  13. Schaefer Katherine L., Wada Koichiro, Takahashi Hirokazu, Matsuhashi Nobuyuki, Ohnishi Shin, Wolfe M. Michael, Turner Jerrold R., Nakajima Atsushi, Borkan Steven C., Saubermann Lawrence J., Peroxisome Proliferator-Activated Receptor γ Inhibition Prevents Adhesion to the Extracellular Matrix and Induces Anoikis in Hepatocellular Carcinoma Cells, 10.1158/0008-5472.can-04-3037
  14. Yu Jun, Qiao Liang, Zimmermann Lars, Ebert Matthias P. A., Zhang Hongxia, Lin Wendy, Röcken Christoph, Malfertheiner Peter, Farrell Geoffrey C., Troglitazone inhibits tumor growth in hepatocellular carcinomain vitroandin vivo, 10.1002/hep.20994
  15. Vidal-Puig A J, Considine R V, Jimenez-Liñan M, Werman A, Pories W J, Caro J F, Flier J S, Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids., 10.1172/jci119424
  16. Cheng Jidong, Nakamura Hideji, Imanishi Hiroyasu, Liu Weidong, Morisaki Takayuki, Sugiyama Toshihiro, Hada Toshikazu, Peroxisome proliferator-activated receptor γ ligands, 15-deoxy-Δ12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells, 10.1016/j.bbrc.2004.07.133
  17. Okano Hiroshi, Shiraki Katsuya, Inoue Hidekazu, Yamanaka Yutaka, Kawakita Tomoyuki, Saitou Yukiko, Yamaguchi Yumi, Enokimura Naoyuki, Yamamoto Norihiko, Sugimoto Kazushi, Murata Kazumoto, Nakano Takeshi, 15-Deoxy-Δ-12-14-PGJ2 Regulates Apoptosis Induction and Nuclear Factor-κB Activation Via a Peroxisome Proliferator-Activated Receptor-γ–Independent Mechanism in Hepatocellular Carcinoma, 10.1097/01.lab.0000092233.50246.f7
  18. Yoshizawa Kaname, Cioca Daniel P., Kawa Shigeyuki, Tanaka Eiji, Kiyosawa Kendo, Peroxisome proliferator-activated receptor ? ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines, 10.1002/cncr.10906
  19. Kawaguchi Kotaro, Sakaida Isao, Tsuchiya Masako, Omori Kaoru, Takami Taro, Okita Kiwamu, Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet, 10.1016/j.bbrc.2004.01.038
  20. Pitot H C, Altered Hepatic FOCI: Their Role in Murine Hepatocarcinogenesis, 10.1146/annurev.pa.30.040190.002341
  21. Guo Yan-Tong, Peroxisome proliferator-activated receptor γ ligands suppress liver carcinogenesis induced by diethylnitrosamine in rats, 10.3748/wjg.v10.i23.3419
  22. Borbath I., Leclercq I., Moulin P., Sempoux C., Horsmans Y., The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver, 10.1016/j.ejca.2007.05.005
  23. Cancer Research, 61, 6213 (2001)
  24. Galli Andrea, Crabb David W., Ceni Elisabetta, Salzano Renata, Mello Tommaso, Svegliati–Baroni Gianluca, Ridolfi Francesco, Trozzi Luciano, Surrenti Calogero, Casini Alessandro, Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro, 10.1053/gast.2002.33666
  25. Hazra Saswati, Xiong Shigang, Wang Jiaohong, Rippe Richard A., Krishna V., Chatterjee K., Tsukamoto Hidekazu, Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells, 10.1074/jbc.m310284200
  26. Planaguma A., The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPAR  activation, 10.1096/fj.04-2753fje
  27. International Journal of Molecular Medicine, 19, 105 (2007)
  28. Leclercq I A, Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats, 10.1136/gut.2005.079194
  29. Belfort Renata, Harrison Stephen A., Brown Kenneth, Darland Celia, Finch Joan, Hardies Jean, Balas Bogdan, Gastaldelli Amalia, Tio Fermin, Pulcini Joseph, Berria Rachele, Ma Jennie Z., Dwivedi Sunil, Havranek Russell, Fincke Chris, DeFronzo Ralph, Bannayan George A., Schenker Steven, Cusi Kenneth, A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis, 10.1056/nejmoa060326
  30. Yamamoto Yui, Nakajima Miki, Yamazaki Hiroshi, Yokoi Tsuyoshi, Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells, 10.1016/s0024-3205(01)01432-1
  31. Li Ming-Yi, Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells, 10.3748/wjg.v9.i8.1683
  32. Li Ming-Yi, PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells, 10.3748/wjg.v9.i6.1220
  33. Oncology Reports, 18, 825 (2007)